(TheNewswire)
December 18, 2020 - 9:00 a.m. EST
LONDON, ONTARIO - TheNewswire – December 18,2020 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leadingclinical-stage regenerative medicine therapeutics company, todayannounces that Dr. Philip Toleikis, President and CEO of Sernova willpresent at the H.C. Wainwright BioConnect 2021 Conference taking placevirtually January 11-14.
Dr. Toleikis is scheduled to host a virtual presentation that will beavailable on demand during the conference, starting at 6:00 AM EST onMonday January 11, 2021. Sernova’s management team will alsoparticipate in one-on-one meetings at the conference.
H.C. Wainwright BioConnect 2021 Conference
Date: Monday, January 11, 2021 to Thursday, January 14, 2021
Time: On demand
Link: https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c
For more information on the H.C. Wainwright BioConnect 2021 Conferenceor to schedule one-on-one meetings with management, please contactyour H.C. Wainwright representative.
ABOUT SERNOVA CORP.
Sernova Corp is developing regenerative medicine therapeutictechnologies using a medical device and immune protected therapeuticcells (i.e. human donor cells, corrected human cells, and stemcell-derived cells) to improve the treatment and quality of life ofpeople with chronic metabolic diseases such as insulin-dependentdiabetes, blood disorders including hemophilia, and other diseasestreated through replacement of proteins or hormones missing or inshort supply within the body. For more information, please visit www.sernova.com
For further information contact:
Dominic Gray
Sernova Corp
Tel: (519) 858-5126
Copyright (c) 2020 TheNewswire - All rights reserved.